KAI Chooses OpenClinica Enterprise for Phase I–IV Clinical Trials
OpenClinica, LLC has announced that Rockville, MD-based KAI Research, Inc., (KAI), an Altarum Company, has selected the OpenClinica Enterprise Edition to power Phase I – IV clinical trials. Founded in 1986, KAI is a full service contract research organization (CRO) that provides innovative, cost-effective, and practical support to pharmaceutical, biotech and academic institutions, and the National Institutes of Health (NIH).
The OpenClinica software enhances clinical trials by streamlining electronic data capture (EDC) and clinical data management. The result is higher quality and faster access to the data.
“KAI is a CRO that relies on cutting edge information technology to help deliver the greatest value to our clients,” states Patti Shugarts, chief operating officer at KAI. She continues: “OpenClinica’s powerful technology and flexible model enable us to deploy a cutting edge EDC that meets the needs of both our industry and government clients.”
The OpenClinica clinical trial software is provided under a commercial open source model, and available in two editions. The OpenClinica Community Edition software is freely available under a widely accepted open source license. The OpenClinica Enterprise Edition consists of a fully validated version of the open source technology with additional capabilities, services, and resource ideal for mission critical research and highly regulated environments. The OpenClinica software is currently in use at over 500 biopharma sponsors, CROs, academic centers, and government agencies worldwide.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Patient Engagement Platform Checklist
November 22nd 2024Modern clinical trials are more complex than ever, and one significant reason is the increased focus on patient engagement. Incorporating a patient engagement platform into your clinical trial enhances the patient experience and can lead to more successful trials with stronger, more reliable outcomes. We put together this helpful checklist of key features to look out for when choosing a platform for your study.
